Roadman Investments Completes Strategic Investment Into Craft Mushroom Distributor and Formulator, Champignon Brands Inc.; Ac...
20 August 2019 - 5:05PM
Roadman Investments Corp. (TSXV: LITT)(FWB: 1QD)(OTC: RMANF)
(“
Roadman Investments” or the
“
Company”) is pleased to announce the Company has
completed a C$150,000.00 strategic investment in British
Columbia-based craft mushroom distributor and product formulator
Champignon Brands Inc. (“Champignon”).
Champignon is a private, research-driven company specializing in
the formulation and end distribution of a suite of premium
artisanal mushroom health supplements, with the objective of
promoting holistic health and wellness. Champignon is equipped with
proprietary formulations for three flagship
mushroom-extract-infused tea blends and is in the process of
conducting extensive taste and product quality tests.
The Company invites all current and prospective shareholders to
visit the Champignon corporate website by following the below
stated URL:
- https://champignonbrands.com/
Luke Montaine, Chief Executive Officer and a Director of Roadman
Investments stated: “Roadman’s tactical deployment of capital into
the burgeoning craft mushroom vertical is indicative of popular
opinion shifting within the space. On May 8th, 2019, Denver voters
approved Initiative 301, a measure that prohibits the city's
government from deploying resources to impose criminal penalties
relating to the consumption and possession of psilocybin by adults
over 21 years of age. The passage of Initiative 301 comes amid a
recent resurgence in the study of psilocybin and its potential
medical applications. Researchers worldwide are increasingly
examining whether psilocybin may alleviate symptoms associated with
conditions such as anxiety, obsessive-compulsive disorder, major
depressive disorder and alcohol dependence.
London-based start-up Compass Pathways has produced 20,000
individual doses of psilocybin for use in clinical trials across
North America and Europe. Compass boasts an advisory board of
esteemed scientists and has attracted high-profile financings from
Peter Thiel, Christian Angermayer and Mike Novogratz, among
others.
Leveraging its newly formed health and wellness committee,
Roadman will continue to actively pursue alpha generating
investments within this flourishing sector. The global mushroom
market accounted for US$38.13 billion in 2017 and is forecasted to
expand at a CAGR of 7.9 per cent from 2018 to 2026. This growth
will be further bolstered by the increasing demand for meat
substitutes, as well as shifting consumer preference towards vegan
foods.”
Champignon’s flagship e-commerce store includes a selection of
craft mushroom-infused teas and ancillary accessories, earmarked
for worldwide distribution. Champignon invites all current and
prospective shareholders to visit its e-commerce store and review
its Vitality Superteas branded product offering by following the
below stated URL:
- https://vitalitysuperteas.com
Kevin Matthews, Advisory Board member and Chair of Roadman
Investments’ Health and Wellness Committee stated: “We continue to
be encouraged by the recent growth within the bourgeoning health
and wellness vertical and are actively looking to deploy additional
capital into promising, high growth companies. As a result of
recent landmark legislative shifts, Roadman’s dedicated Health and
Wellness committee is currently evaluating complimentary
investments within the medicinal mushroom sector, with the
objective of augmenting Champignon’s mushroom-extract-infused tea
formulations”.
About Roadman Investments Roadman Investments
is a Canadian Venture Capital and Advisory Firm that strives to
actively drive innovation and accelerate growth within its
portfolio holdings in order to realize alpha returns for its
shareholders. Roadman invests capital into companies that offer
breakthrough products, devices, treatments and health
supplements.
For further information, please contact:
Media Contact:Nikolai Vassev
nik@roadmaninvestments.com +1 778-772-1751
Neither the TSX Venture Exchange nor its Regulation
Services Provider (as that term is defined in the policies of the
TSX Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
Caution Regarding Forward-Looking Statements –
This news release contains certain forward-looking statements,
including statements regarding the business of the Company. These
statements are subject to a number of risks and uncertainties.
Actual results may differ materially from results contemplated by
the forward-looking statements. When relying on forward-looking
statements to make decisions, investors and others should carefully
consider the foregoing factors and other uncertainties and should
not place undue reliance on such forward-looking statements. The
Company does not undertake to update any forward looking
statements, oral or written, made by itself or on its behalf except
as required by law.
Right Season Investments (TSXV:LITT)
Historical Stock Chart
From Jun 2024 to Jul 2024
Right Season Investments (TSXV:LITT)
Historical Stock Chart
From Jul 2023 to Jul 2024